CATS - Catasys, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
3.61
-0.23 (-5.99%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.84
Open3.81
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.57 - 3.89
52 Week Range3.56 - 14.00
Volume97,491
Avg. Volume48,429
Market Cap57.36M
Beta0.90
PE Ratio (TTM)-2.23
EPS (TTM)-1.62
Earnings DateNov 13, 2017 - Nov 17, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.00
Trade prices are not sourced from all markets
  • Marketwired4 days ago

    Taglich Brothers Initiates Coverage of Catasys, Inc.

    Taglich Brothers, Inc. announces it has initiated coverage of Catasys, Inc. .Catasys, headquartered in Los Angeles, California, provides specialized behavioral health management and integrated treatment ...

  • How Long Will Catasys Inc’s (CATS) Cash Last?
    Simply Wall St.18 days ago

    How Long Will Catasys Inc’s (CATS) Cash Last?

    Catasys Inc (NASDAQ:CATS) continues its loss-making streak, announcing a -$16.77M earnings for its latest financial year ending. Cash is crucial to run a business, and if a company burns throughRead More...

  • Catasys, Inc. :CATS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017
    Capital Cube23 days ago

    Catasys, Inc. :CATS-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017

    Categories: Yahoo FinanceGet free summary analysis Catasys, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 1.67 million, Net Earnings of USD 13.93 million. Gross margins widened from 2.37% to 17.30% compared to the same period last year, operating (EBITDA) margins now -156.58% from -169.66%. Change in operating cash ... Read more (Read more...)

  • Business Wirelast month

    Catasys to Present at the Dougherty & Company Institutional Investor Conference on September 19, 2017

    Catasys, Inc. , a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that Terren Peizer, Chairman & Chief Executive Officer, will present at the Dougherty & Company Institutional Investor Conference on September 19th, 2017 at the Millennium Hotel in Minneapolis, Minnesota.

  • Business Wirelast month

    Catasys Chief Medical Officer, Dr. Omar Manejwala to Present at TAHP Medical Directors Forum

    Catasys, Inc. , a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that the company’s Senior Vice President and Chief Medical Officer, Omar Manejwala, M.D., will be presenting at the TAHP Medical Directors Forum on Friday, September 8, 2017 at The Hotel Contessa in San Antonio, Texas.

  • Business Wire2 months ago

    Catasys Expands OnTrak-A Solution to Connecticut with Leading National Health Insurance Plan

    Catasys, Inc. , a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it has expanded its OnTrak-A program to Connecticut with one of the nation’s leading health insurance companies.

  • Business Wire2 months ago

    Catasys Reports 2017 Second Quarter Financial Results

    Catasys, Inc. , a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today reported its financial results for the second quarter and six months ended June 30, 2017.

  • ACCESSWIRE2 months ago

    Investor Network: Catalyst Semiconductor Inc Com to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 15, 2017 / Catalyst Semiconductor Inc Com (NASDAQ: CATS ) will be discussing their earnings results in their Q2 Earnings Call to be held August 15, 2017 at 4:30 PM Eastern ...

  • ACCESSWIRE2 months ago

    Corporate News Blog - Catasys Announces Launch of Enrollment for OnTrak-HC with Blue Cross Blue Shield Health Insurer

    Research Desk Line-up: DaVita Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 11, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Catasys, ...

  • Business Wire2 months ago

    Catasys Announces Launch of Enrollment with Second Largest Blue Cross Blue Shield Health Insurer

    Catasys, Inc. , a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it has commenced enrollment under the previously announced contract for its OnTrak-HC program in Oklahoma with the nation's second largest Blue Cross Blue Shield health insurance plan.

  • Business Wire3 months ago

    Catasys Announces Program Expansion with Leading National Health Insurance Plan to Include Anxiety Disorder

    Catasys, Inc. , a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it has expanded its OnTrak-A program with one of the nation's leading health insurance providers to now include anxiety in three states: Illinois, Kansas and Missouri.

  • Business Wire3 months ago

    Catasys to Announce Second Quarter 2017 Results and Host Conference Call on Tuesday, August 15th, 2017

    Catasys, Inc. , a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced that the Company will be releasing its second quarter ended June 30, 2017 financial results after the closing of the stock market on Tuesday, August 15th, 2017.

  • Catasys, Inc. :CATS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017
    Capital Cube5 months ago

    Catasys, Inc. :CATS-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Catasys, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Catasys, Inc. – Birner Dental Management Services, Inc., Magellan Health, Inc. and HMS Holdings Corp. (BDMS-US, MGLN-US and HMSY-US) that have also reported for this period. Highlights Summary numbers: ... Read more (Read more...)

  • Accesswire5 months ago

    Catasys to Participate in the 7th Annual LD Micro Invitational on June 6th

    LOS ANGELES, CA / ACCESSWIRE / June 5, 2017 / Catasys, Inc. (NASDAQ: CATS) a provider of proprietary predictive analytics and integrated treatment solutions to health insurance plans, today announced that ...

  • PR Newswire5 months ago

    Catasys to Increase Enrollment for OnTrak-A in Eight States with Leading National Health Insurance Plan

    Catasys, Inc. (CATS) a provider of proprietary predictive analytics and integrated treatment solutions to health insurance plans, announced today that it is now receiving all of the member data expected from a leading national health insurance plan, which will allow the Company to fully ramp enrollment for OnTrak-A in the eight contracted states. The previously announced data issues on the customer's end, which prevented Catasys from properly identifying members, have been resolved.  The data feed from the customer had previously been operating at what Catasys believed to be approximately 5 to 10 percent of capacity. However, with the complete data now available, Catasys believes the eligible lives included in this customer's member population is approximately 50 percent higher than anticipated.  Despite the limitations of this program over the last year, Catasys was still able to generate $8.5 million in total cash receipts for 2016.  Obviously, this speaks well for the coming quarters and years.

  • PR Newswire5 months ago

    Catasys Begins Enrollment for OnTrak-C Solution in Texas with Leading National Health Insurance Provider

    Medicaid populations represent approximately 2.5 fold greater  revenue opportunity than comparable commercial populations. Catasys, Inc. (CATS) a provider of proprietary predictive analytics and integrated treatment solutions to health insurance plans, announced today that it has launched enrollment under the previously announced contract for its OnTrak™-C solution coverage in Texas with one of the nation's leading health insurance plans.

  • Accesswire5 months ago

    Investor Network: Catalyst Semiconductor Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 16, 2017 / Catalyst Semiconductor Inc Com (NASDAQ: CATS ) will be discussing their earnings results in their Q1 Earnings Call to be held May 16, 2017 at 11:00 AM Eastern ...

  • PR Newswire5 months ago

    Catasys Appoints New Chief Financial Officer

    LOS ANGELES, May 16, 2017 /PRNewswire/ -- Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today announced the appointment of Christopher Shirley as its new Chief Financial Officer, effective immediately. Mr. Shirley succeeds Susan Etzel, who was appointed SVP of Finance and will remain a key member of the Company's financial team.

  • PR Newswire5 months ago

    Catasys Revenue Increased 150% in the First Quarter of 2017

    LOS ANGELES, May 15, 2017 /PRNewswire/ -- -  Deferred Revenue increased $419,000 to $1.9 million in the three months ended March 31, 2017 - Total cash receipts increased 8% to $2.2 million for the first ...

  • PR Newswire5 months ago

    Catasys to Announce First Quarter 2017 Results

    LOS ANGELES, May 10, 2017 /PRNewswire/ -- Catasys, Inc. (NASDAQ: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it will report ...

  • PR Newswire6 months ago

    Catasys Further Strengthens Balance Sheet with Conversion of all Debt into Common Stock

    LOS ANGELES, May 1, 2017 /PRNewswire/ -- Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that it has strengthened its balance sheet with the conversion of its outstanding convertible debt and deferred compensation. Acuitas Group Holdings, LLC, which is owned by Terren Peizer, Chairman and Chief Executive Officer of the Company, converted convertible debenture $4,293,198 to equity.

  • PR Newswire6 months ago

    Catasys Announces Closing of $15 Million Public Offering

    LOS ANGELES, April 28, 2017 /PRNewswire/ -- Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today announced the closing of its previously announced underwritten public offering of 3,125,000 shares of common stock. The aggregate gross proceeds to Catasys from the public offering were $15 million prior to deducting underwriting discounts, commissions and other estimated offering expenses. Catasys has granted the underwriters a 45-day option to purchase up to an additional 468,750 shares of common stock to cover over-allotments, if any.

  • PR Newswire6 months ago

    Catasys to Participate in Joseph Gunnar's Pioneers 2017 Conference on May 2

    LOS ANGELES, April 27, 2017 /PRNewswire/ -- Catasys, Inc. (NasdaqCM: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that Terren ...

  • PR Newswire6 months ago

    Catasys to Present at RedChip's Global Online Growth Conference on April 27

    LOS ANGELES, April 26, 2017 /PRNewswire/ -- Catasys, Inc. (NasdaqCM: CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, announced today that Terren ...

  • PR Newswire6 months ago

    Catasys Announces $15 Million Public Offering and NASDAQ Listing

    LOS ANGELES, April 25, 2017 /PRNewswire/ -- Catasys, Inc. (CATS), a provider of proprietary predictive analytics and integrated treatment solutions to health plans, today announced the pricing of an underwritten public offering of 3,125,000 shares of common stock at a public offering price of $4.80 per share. The aggregate gross proceeds to Catasys from the public offering are expected to be $15 million prior to deducting underwriting discounts, commissions and other estimated offering expenses.